Literature DB >> 11966496

Corpus gastritis in patients with endoscopic diagnosis of reflux oesophagitis and Barrett's oesophagus.

R J F Laheij1, L G M Van Rossum, W A De Boer, J B M J Jansen.   

Abstract

BACKGROUND: A high level of gastric acid secretion is considered to be a risk factor for reflux oesophagitis or Barrett's oesophagus. Corpus gastritis may have a protective effect on the oesophagus, because of decreased gastric acid output. AIM: To determine if corpus gastritis is associated with reflux oesophagitis or Barrett's oesophagus.
METHODS: Three antral and two corpus biopsies were taken from consecutive patients in whom Helicobacter pylori testing was requested during endoscopy at a single centre between January 1995 and May 1997. Antral and corpus gastritis was studied by histology; H. pylori was studied by histology, culture and CLO test. A regression model was used to test for correlation between reflux oesophagitis, Barrett's oesophagus and risk factors.
RESULTS: During the study period, 676 patients had biopsies taken during upper gastrointestinal endoscopy. Endoscopic signs of reflux oesophagitis and Barrett's oesophagus were observed in 125 and 23 patients, respectively. Corpus gastritis was found in 59% of patients without reflux oesophagitis or Barrett's oesophagus, 45% of patients with reflux oesophagitis and 30% of patients with Barrett's oesophagus. Two hundred and fifty-seven patients underwent follow-up endoscopy after H. pylori therapy. During a mean follow-up of 3 months, the incidence of reflux oesophagitis was not statistically different for patients with healing of corpus gastritis (10/98; 10%) and patients with persistent gastritis (8/97; 8%).
CONCLUSIONS: Corpus gastritis was less common in patients with an endoscopic diagnosis of reflux oesophagitis or Barrett's oesophagus.

Entities:  

Mesh:

Year:  2002        PMID: 11966496     DOI: 10.1046/j.1365-2036.2002.01245.x

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  8 in total

1.  CagA in Barrett's oesophagus in Colombia, a country with a high prevalence of gastric cancer.

Authors:  M Kudo; O Gutierrez; H M T El-Zimaity; H Cardona; Z Z Nurgalieva; J Wu; D Y Graham
Journal:  J Clin Pathol       Date:  2005-03       Impact factor: 3.411

2.  Low circulating levels of gastrin-17 in patients with Barrett's esophagus.

Authors:  Pentti Sipponen; Matti Vauhkonen; Timo Helske; Ilpo Kaariainen; Matti Harkonen
Journal:  World J Gastroenterol       Date:  2005-10-14       Impact factor: 5.742

3.  The association between Barrett's esophagus and Helicobacter pylori infection: a meta-analysis.

Authors:  Lori A Fischbach; Helena Nordenstedt; Jennifer R Kramer; Subi Gandhi; Sam Dick-Onuoha; Anthony Lewis; Hashem B El-Serag
Journal:  Helicobacter       Date:  2012-03-20       Impact factor: 5.753

4.  Association of Barrett's esophagus with Helicobacter pylori infection: a meta-analysis.

Authors:  Shaoze Ma; Xiaozhong Guo; Chunmei Wang; Yue Yin; Guangqin Xu; Hongxin Chen; Xingshun Qi
Journal:  Ther Adv Chronic Dis       Date:  2022-08-22       Impact factor: 4.970

5.  CagA-positive Helicobacter pylori infection is not associated with decreased risk of Barrett's esophagus in a population with high H. pylori infection rate.

Authors:  Angel Ferrández; Rafael Benito; Juan Arenas; María Asunción García-González; Federico Sopeña; Javier Alcedo; Javier Ortego; Ricardo Sainz; Angel Lanas
Journal:  BMC Gastroenterol       Date:  2006-02-16       Impact factor: 3.067

6.  The Benefits of Combination Therapy with Esomeprazole and Rebamipide in Symptom Improvement in Reflux Esophagitis: An International Multicenter Study.

Authors:  Su Jin Hong; Soo-Heon Park; Jeong Seop Moon; Woon Geon Shin; Jae Gyu Kim; Yong Chan Lee; Dong Ho Lee; Jae Young Jang; Jae J Kim; Hang-Lak Lee; Sang Woo Lee; Young Hwangbo; Jianming Xu; Bangmao Wang; Zhanxiong Xue; Fei Liu; Yaozong Yuan; Somchai Leelakusolvong; Frederick Dy
Journal:  Gut Liver       Date:  2016-11-15       Impact factor: 4.519

Review 7.  Helicobacter pylori infection reduces the risk of Barrett's esophagus: A meta-analysis and systematic review.

Authors:  Bálint Erőss; Nelli Farkas; Áron Vincze; Benedek Tinusz; László Szapáry; András Garami; Márta Balaskó; Patrícia Sarlós; László Czopf; Hussain Alizadeh; Zoltán Rakonczay; Tamás Habon; Péter Hegyi
Journal:  Helicobacter       Date:  2018-06-25       Impact factor: 5.753

8.  Helicobacter pylori infection is associated with reduced risk of Barrett's esophagus: a meta-analysis and systematic review.

Authors:  Yan-Lin Du; Ru-Qiao Duan; Li-Ping Duan
Journal:  BMC Gastroenterol       Date:  2021-12-07       Impact factor: 3.067

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.